2016 American Transplant Congress » Poster Session D: Late Breaking

6:00pm-7:00pm

Accepted Mouse Kidney Allografts Are Characterized by Widespread Nitrosylation.

I. Aljabban, B. Jiang, C. Yang, D. Ndishabandi, R. White, P. Russell, J. Madsen, R. Colvin, A. Alessandrini.

6:00pm-7:00pm

An In-Situ Treatment of Donor Skin Induces MARCH1 and Decreases MHC II Expression on Donor Dendritic Cells, Promoting Skin Allograft Acceptance.

T. Borges,^1,2 F. Machado,¹ C. Bonorino,¹ L. Riella.²

6:00pm-7:00pm

Determinants of 1 Year Graft Loss After Pre Kidney Transplant Bariatric Surgery.

G. Mour, J. Zhang, Z. Su, D. Taber, P. Mauldin, T. Srinivas.

6:00pm-7:00pm

Genetic TIM-4 Deletion Promotes Immunoregulatory Tissue-Resident Macrophage Survival and Lowers the Barrier to Cardiac Allograft Tolerance.

T. Thornley,¹ P. Kyriazis,¹ K. Agarwal,¹ Z. Fang,¹ L. Ma,¹ V. Chipashvili,¹ M. Koulmanda,^1,2 T. Strom.^1,2

6:00pm-7:00pm

Initial Experience with the Bacterial Enzyme IdeS® (IgG Endopeptidase) for Desensitization of Highly-HLA Sensitized (HS) Patients.

S. Jordan,¹ J. Choi,¹ X. Zhang,¹ M. Haas,² A. Peng,¹ J. Kahwaji,¹ R. Villicana,¹ A. Vo.¹

6:00pm-7:00pm

Ischemia-Reperfusion Injury Following Transplantation: Implications for the Modulation of CXCL8 Chemokine Function.

B. Martinez Burgo,¹ S. Ali,¹ J. Kirby,¹ N. Sheerin,¹ S. Cobb,² D. Kashanin.³

6:00pm-7:00pm

Kidney Transplant Recipient Adherence Measured by Proportion of Days Covered Is Associated with Late Biopsy Proven Acute Rejection.

B. Hofmeyer, K. Look, J. Fose, A. Pulvermacher, A. Djamali, D. Hager.

6:00pm-7:00pm

Liver Transplantation (LT) Using Liver Allografts from Deceased After Cardiac Death (DCD) Donors: Opinions, Practices and Reality.

L. Sher,¹ P. Abt,² Y. Genyk,¹ M. Lo,¹ P. Yan,¹ L. Ji,¹ C. Marsh.³

6:00pm-7:00pm

Potential Biomarkers and Treatment for BK Virus Associated Nephropathy.

M. Borkar,¹ V. Srivastava,² R. Cunnington,¹ T. Sharma,¹ L. Tibbles.¹

6:00pm-7:00pm

Pulse Wave Velocity Amongst African-American Kidney Transplant Recipients Randomized to Once-Daily MeltDose Tacrolimus Tablets (Envarsus XR) vs. Traditional Twice-Daily Tacrolimus Capsules: Exploratory Results from a Phase III Trial.

J. Trofe-Clark,^1,2 R. Townsend,² R. Neubauer,² M. Lim,² L. Callahan,³ R. Bloom.²

6:00pm-7:00pm

Real Time Assessment of Kidney Transplant Indication Biopsies by Microarrays: First Results of the INTERCOMEX Study.

P. Halloran,^1,2 J. Reeve,¹ INTERCOMEX Study Group.

6:00pm-7:00pm

The Distance Between Us: The Landscape of Recipient-Specific Loss-of-Function in Solid Organ Transplantation and Association with Rejection-Free Graft Survival.

B. Cole,^1,2,5 J. van Setten,^3,5 B. Keating.^1,4,5

6:00pm-7:00pm

The UK ONE Study: Safety and Feasibility of Regulatory T Cell Therapy in Renal Transplantation.

A. Bushell,¹ J. van der Net,^1,2 D. Game,³ R. Hilton,³ S. Thirkell,⁴ P. Friend,² E. Geissler,⁵ K. Wood,¹ P. Harden,² G. Lombardi.⁴

6:00pm-7:00pm

Therapeutically Equivalent Results to Caucasians in Black Kidney Transplant Recipients Using ASTAGRAF XL^® Despite a Higher Degree of HLA Mismatch : A Post-Hoc Analysis of Phase III Data from Over 2000 Patients.

J. Schwartz, S. Wilson, F. Shi, N. Undre, M. Kumar.